Clinical Trial Update: Calcineurin Inhibitor-Free Interventions BMT CTN 1301 for Prevention of Graft-versus-Host Disease (BMT CTN 1301) [Phase 3]

View source ↗

Summary

Phase 3 trial update for calcineurin inhibitor–free interventions to prevent graft-versus-host disease after transplantation has completed; results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Syndromes

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Acute Leukemia, Myelodysplasia | Phase 3 | Status: COMPLETED | Results posted: 2021-12-21